MAIA Biotechnology, Inc. – AMEX:MAIA

MAIA Biotechnology stock price today

$1.52
-0.56
-27.27%
Financial Health
0
1
2
3
4
5
6
7
8
9

MAIA Biotechnology stock price monthly change

-42.74%
month

MAIA Biotechnology stock price quarterly change

-42.74%
quarter

MAIA Biotechnology stock price yearly change

+75.63%
year

MAIA Biotechnology key metrics

Market Cap
49.77M
Enterprise value
N/A
P/E
-2.27
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
4.18
PEG ratio
0.04
EPS
-1.54
Revenue
N/A
EBITDA
-19.89M
Income
-23.72M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

MAIA Biotechnology stock price history

MAIA Biotechnology stock forecast

MAIA Biotechnology financial statements

MAIA Biotechnology, Inc. (AMEX:MAIA): Profit margin
Jun 2023 0 -4.52M
Sep 2023 0 -4.87M
Dec 2023 0 -6.25M
Mar 2024 0 -8.06M
MAIA Biotechnology, Inc. (AMEX:MAIA): Analyst Estimates
2027 219.73M 35.80M 16.3%
  • Analysts Price target

  • Financials & Ratios estimates

MAIA Biotechnology, Inc. (AMEX:MAIA): Earnings per share (EPS)
2023-11-08 -0.38 -0.36
2024-03-21 -0.35 -0.41
2024-05-14 -0.33 -0.46
MAIA Biotechnology, Inc. (AMEX:MAIA): Debt to assets
Jun 2023 10268763 3.39M 33.06%
Sep 2023 7001073 4.25M 60.75%
Dec 2023 7566852 7.08M 93.69%
Mar 2024 8716036 14.48M 166.14%
MAIA Biotechnology, Inc. (AMEX:MAIA): Cash Flow
Jun 2023 -2.56M -4.26M 4.11M
Sep 2023 -3.15M 341.05K 125.94K
Dec 2023 -3.99M 3.91M 5.02M
Mar 2024 -3.58M 0 4.71M

MAIA Biotechnology alternative data

MAIA Biotechnology, Inc. (AMEX:MAIA): Employee count
Aug 2023 18
Sep 2023 18
Oct 2023 18
Nov 2023 18
Dec 2023 18
Jan 2024 18
Feb 2024 18
Mar 2024 18
Apr 2024 18
May 2024 18
Jun 2024 13
Jul 2024 13

MAIA Biotechnology other data

0.77% -2.15%
of MAIA is owned by hedge funds
71.53K -225.59K
shares is hold by hedge funds

MAIA Biotechnology, Inc. (AMEX:MAIA): Insider trades (number of shares)
Period Buy Sel
Mar 2024 905462 0
Apr 2024 334314 0
Nov 2024 465600 0
Dec 2024 156836 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SMITH STAN director
Common Stock 25,000 $1.87 $46,800
Purchase
SMITH STAN director
Warrants 25,000 $2.08 $52,000
Purchase
GUERRERO RAMIRO director
Common Stock 53,418 $1.87 $99,998
Purchase
GUERRERO RAMIRO director
Warrants 53,418 $2.08 $111,109
Purchase
LUPUT CRISTIAN director
Common Stock 22,133 $2.51 $55,554
Purchase
LUPUT CRISTIAN director
Warrants 22,133 $2.26 $49,998
Purchase
CHAOUKI STEVEN M director Common Stock 22,133 $2.51 $55,554
Purchase
CHAOUKI STEVEN M director Warrants 22,133 $2.26 $49,998
Purchase
GUERRERO RAMIRO director
Common Stock 88,534 $2.51 $222,220
Purchase
GUERRERO RAMIRO director
Warrants 88,534 $2.26 $199,998
Monday, 16 December 2024
businesswire.com
Monday, 9 December 2024
businesswire.com
Tuesday, 3 December 2024
businesswire.com
Tuesday, 5 November 2024
businesswire.com
Monday, 28 October 2024
businesswire.com
Tuesday, 23 July 2024
businesswire.com
Friday, 7 June 2024
businesswire.com
Thursday, 6 June 2024
businesswire.com
Tuesday, 4 June 2024
businesswire.com
Friday, 17 May 2024
businesswire.com
Thursday, 16 May 2024
businesswire.com
Tuesday, 30 April 2024
businesswire.com
Monday, 29 April 2024
businesswire.com
Tuesday, 23 April 2024
businesswire.com
Friday, 5 April 2024
Business Wire
Friday, 5 January 2024
Business Wire
Thursday, 4 January 2024
Seeking Alpha
Friday, 1 December 2023
Zacks Investment Research
Thursday, 19 October 2023
Business Wire
Saturday, 1 July 2023
Seeking Alpha
Thursday, 29 June 2023
InvestorPlace
Wednesday, 12 April 2023
Zacks Investment Research
Thursday, 5 January 2023
Business Wire
Thursday, 29 September 2022
Business Wire
Tuesday, 6 September 2022
Business Wire
  • What's the price of MAIA Biotechnology stock today?

    One share of MAIA Biotechnology stock can currently be purchased for approximately $1.52.

  • When is MAIA Biotechnology's next earnings date?

    Unfortunately, MAIA Biotechnology's (MAIA) next earnings date is currently unknown.

  • Does MAIA Biotechnology pay dividends?

    No, MAIA Biotechnology does not pay dividends.

  • How much money does MAIA Biotechnology make?

    MAIA Biotechnology has a market capitalization of 49.77M. MAIA Biotechnology made a loss 19.77M US dollars in net income (profit) last year or -$0.46 on an earnings per share basis.

  • What is MAIA Biotechnology's stock symbol?

    MAIA Biotechnology, Inc. is traded on the AMEX under the ticker symbol "MAIA".

  • What is MAIA Biotechnology's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of MAIA Biotechnology?

    Shares of MAIA Biotechnology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does MAIA Biotechnology have?

    As Jul 2024, MAIA Biotechnology employs 13 workers, which is 28% less then previous quarter.

  • When MAIA Biotechnology went public?

    MAIA Biotechnology, Inc. is publicly traded company for more then 3 years since IPO on 28 Jul 2022.

  • What is MAIA Biotechnology's official website?

    The official website for MAIA Biotechnology is maiabiotech.com.

  • Where are MAIA Biotechnology's headquarters?

    MAIA Biotechnology is headquartered at 444 West Lake Street, Chicago, IL.

  • How can i contact MAIA Biotechnology?

    MAIA Biotechnology's mailing address is 444 West Lake Street, Chicago, IL and company can be reached via phone at +31 24168592.

MAIA Biotechnology company profile:

MAIA Biotechnology, Inc.

maiabiotech.com
Exchange:

AMEX

Full time employees:

13

Industry:

Biotechnology

Sector:

Healthcare

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

444 West Lake Street
Chicago, IL 60606

CIK: 0001878313
ISIN: US5526411021
CUSIP: 552641102